Genesys Capital — Full Portfolio
18 tracked investments · listed companies and verified rows first
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)
Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.
AI & Machine LearningBiotechDeep TechHamilton, CA
Nathan Magarvey(Founder)
Co-investorsPfizer Venture Investments
Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.
Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.
BiotechDeep TechHardwareHealthtechMedical Devices
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners
Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.
HealthtechMedical Devices
Co-investorsJobsOhio Ventures
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsLinearis VenturesFonds de solidarité FTQZynext Ventures
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios Capital+2 more
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adapsyn Bioscience IncFunction NeuromodulationFusionGiiantGiiant Pharma IncQuestat IncVeralox Therapeutics Inc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.